The EIF2AK4 Knockout A-549 Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal population derived from the A-549 human lung adenocarcinoma cell line, featuring targeted disruption of the EIF2AK4 gene. This gene encodes the amino acid-sensing kinase GCN2, a central component of the integrated stress response. The polyclonal format provides a heterogeneous pool of knockout cells, enabling investigation of GCN2 loss-of-function in a physiologically relevant epithelial adenocarcinoma context without clonal selection bias.
The parental A-549 cell line is a well-established model of human lung adenocarcinoma, originally derived from a 58-year-old male patient. These adherent epithelial cells are widely employed in respiratory research, drug metabolism, and toxicity studies due to their robust growth characteristics and retention of key signaling pathways. A-549 cells are particularly valuable for studying cancer biology, including tumor progression, metastasis, and therapeutic resistance, and they serve as a standard platform for evaluating pharmacological interventions in lung cancer.
EIF2AK4 encodes GCN2, a serine/threonine kinase that serves as a primary sensor of amino acid deprivation. Upon uncharged tRNA accumulation, GCN2 is activated by the GCN1?CGCN20 complex and PACT, phosphorylating eIF2??. This phosphorylation inhibits global translation while upregulating ATF4 translation. ATF4, a master transcription factor, induces stress-responsive genes including CHOP, GADD34, and autophagy regulators. GCN2 integrates amino acid availability with downstream signaling through mTORC1, ULK1, and LC3, linking nutrient sensing to protein homeostasis and cell survival.
Knockout of EIF2AK4 in A-549 cells abolishes the GCN2-dependent phosphorylation of eIF2?? in response to amino acid starvation, thereby disrupting the integrated stress response and downstream activation of ATF4 and its transcriptional targets. This model is highly relevant for dissecting the role of GCN2 in lung adenocarcinoma biology, where nutrient limitation and metabolic stress are common features of the tumor microenvironment. Disruption of this pathway can alter cell survival, autophagy, and metabolic adaptation, providing a powerful tool for investigating mechanisms of drug resistance and for evaluating GCN2-targeted therapeutics in a lung cancer context.
The EIF2AK4 Knockout A-549 Polyclonal Cells are suitable for studying amino acid sensing, stress responses, cancer metabolism, and autophagy. Key assays include Western blotting for phospho-eIF2?? and ATF4, RT-qPCR for ATF4 targets, amino acid deprivation experiments, cell viability under nutrient stress, and autophagy flux measurements via LC3-II turnover. Seahorse metabolic flux analysis can profile bioenergetic changes. These cells are valuable for GCN2 inhibitor screening and exploring crosstalk between the integrated stress response and mTOR signaling. For further information, contact Ascent Research.
